Public annual accounts

DM-Pharma financials

Name: DM-Pharma financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for DM-Pharma, with comparable measures and links to available source documents.

Company overview

Registry number

0760881856

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 28, 2026

Financial evidence

Latest movements for DM-Pharma

2025 versus 2024

Operating line: €16,838
EBITDA: €15,094
Total assets: €217,870
Equity: €49,542

EBITDA margin +89.6% · Equity ratio +22.7%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€16,838	€15,094	€217,870	€49,542	-
202431 Dec 2024	€52,731	€51,250	€240,882	€76,534	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report